| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |